IPO - Profile

Summary

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$11.00 7,000,000 Positive High 79.26%

Offering Team

  • Legal counsel
  • McDermott Will & Emery LLP
  • Auditors
  • Grant Thornton LLP

Deal Highlights

We are an experienced, fast-growing national provider of body contouring procedures delivering a premium consumer experience. At Elite Body Sculpture, we provide custom body contouring using our proprietary AirSculpt® method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. It is our mission to generate the best results for our patients. We believe our treatment results and elite patient experience have positioned Elite Body Sculpture as a preferred body contouring brand. We performed over 5,800 body contouring procedures in 2020. Our proprietary and patented AirSculpt® method is minimally invasive because it requires no needle, no scalpel, no stitches and no general anesthesia to achieve transformational change that appears both natural and smooth. Our patients are guided by surgeons and patient care consultants through every step of the experience. Our patients are awake and can converse with their surgeon or listen to music during their procedure and often resume normal activity the next day.

Deal Tracker

IPO Dates

Filing 28 Oct, 2021

Offer 29 Oct, 2021

Look Ahead

Lock Up Expiry Apr 29, 2022

IPO Terms

Offer Price $11.00
Offer Size 7M

Market Sentiments

Stock Price